92
Participants
Start Date
August 20, 2019
Primary Completion Date
March 26, 2021
Study Completion Date
April 23, 2021
Roxadustat
Roxadustat will be administered per schedule specified in the arm description.
Research Center, The Bronx
Research Center, Port Jefferson Station
Research Center, Gettysburg
Research Center, Philadelphia
Research Center, Bethesda
Research Center, Jacksonville
Research Center, Plantation
Research Center, Ashland
Research Center, Canton
Research Center, Fort Wayne
Research Center, Covington
Research Center, Los Angeles
Research Center, Torrance
Research Center, Los Alamitos
Research Center, Livingston
Lead Sponsor
Collaborators (2)
AstraZeneca
INDUSTRY
Astellas Pharma Inc
INDUSTRY
FibroGen
INDUSTRY